We have developed a new method to co-localize multiple glycosyl transferases in different Golgi compartments. The approach relies on the proven ability of intact, sealed rat liver Golgi preparations to concentrate exogenous labeled sugar nucleotides into the lumen where they glycosylate either endogenous or artificial acceptors. The premise is that if two glycosyl transferases are co-localized within the same compartment, they will compete for the limited amount of transported donor. If the donor is consumed in glycosylating a permeable artificial glycoside within a Golgi compartment, it will be unavailable to glycosylate endogenous products within that same compartment. The greater the degree of transferase co-localization, the greater the potential decrease in glycosylation of endogenous acceptors. We provide an example consistent with these predictions. Adding 1 fiM UDP ]Gal/31 -> 4GlcNAc/31 -» R structures in neutral and mono-sialylated oligosaccharides; synthesis of these structures in di-and tri-sialylated oligosaccharides was unaffected. These preferential decreases are not seen in detergent permeabilized, sugar nucleotide transport-independent Golgi incubations, and are not due to inhibition by the Gal/31,4Xyl/3MU product. These results argue that there is significant overlap in the functional co-localization of sialyl and galactosyltransferases in rat liver Golgi preparations and that GAG chain core specific Galactosyltransfera.se I is co-localized with subsets of N-glycan Gal/31,3 and Gal/31,4 transferases. This approach can be used with other glycosides and sugar nucleotides to map and co-localize other glycosyl transferases. The functional compartments defined by this approach may or may not correspond entirely with morphologically defined Golgi domains.
Introduction
A popular view of the Golgi organization and function is that glycosyl transferases are sequentially ordered with the morphologically defined cis, medial, trans compartments roughly corresponding to the known order of glycosylations (Goldberg and Kornfeld, 1983; Rothman and Orci, 1990,1992; Roth, 1991; Barinaga 1993) . This view primarily addresses the early steps in N-linked glycosylation (Dunphy et al., 1985) , but the later steps in this pathway, Olinked glycosylation, and most of the GAG synthesis, may occur in the trans-Golgi (Griffiths and Simons, 1986 ) and trans-Golgi network (TGN) (Geuze and Morre, 1991 ). An alternative perspective of the Golgi is that the glycosyl transferase organization is more flexible and cell type dependent (Bretscher and Munro, 1993; Nilsson et al., 1993 Nilsson et al., , 1994 Velasco et al., 1993) . These perspectives are based on conventional methods, such as the use of metabolic inhibitors (swainsonine, Brefeldin A, and monensin) to selectively block different steps of glycan synthesis, immunolocalization of glycosyltransferase antigens, and distribution of glycosyltransferase activities after fractionation of membranes and vesicles by differential centrifugation (Goldberg and Kornfeld, 1983; Roth, 1991; Sampath etal., 1992) . Despite the considerable success of these approaches, each method has some shortcomings. For example, metabolic inhibitors may alter cellular homeostasis and this may induce redistribution artifacts. Immunolocalization of transferases measures antigen localization but not necessarily the functionally active glycosyl transferases; however, in a few cases, a transferase has been co-localized with its immediate product (Roth et al., 1994) . Enzyme assays of gradient fractions require solubilization of the enzymes and the addition of exogenous substrates and acceptors. Once an enzyme is solubilized, it is impossible to tell if co-fractionating glycosyl transferases actually resided in the same compartment and with their substrates.
Regardless of the specific distribution of glycosyl transferases, any glycosylation step requires that a functionally active Golgi compartment have sugar nucleotide transporters to deliver the donors to spatially and temporally colocalized glycosyl transferases and nearby acceptors (Varki, 1991) . In the dynamic setting of the living cell, vesicular trafficking (transport) continuously delivers maturing glycoconjugates from one compartment to the next. In an in vitro, non-transporting, static system, a functional compartment defines itself by having all the essential components spatially co-localized. This concept was recently exploited by Hayes et al. (1993) in a series of papers showing that endogenous acceptors in sealed Golgi vesicles could be radiolabeled by a sugar nucleotide transportermediated process. A chase with non-labeled sugar nucleotides led to further glycosylation of the labeled endogenous acceptors. Since this occurred in the absence of intervesicu-lar transport, all of the contributing transporters and transferases involved in the labeling and subsequent glycosylation of the products resided in a such functional compartments as defined above.
We extended this approach by showing that a small, freely diffusable glycoside, Xyl/3MU, could also be glycosylated in these static Golgi preparations. This compound is a specific acceptor for the addition of galactose by GAG core galactosyltransferase I to make the core precursor, Gal/31,4Xyl/3MU (Freeze et ai, 1993; Etchison et ai, 1995) . We reasoned that the glycosylation of this diffusable acceptor at saturating concentrations could limit the availability of the transported sugar nucleotides for other co-localized glycosyltransferases, and thus act as a sink for the limited amount of transported donor. This, in turn, would limit the glycosylation of the trace amounts of endogenous acceptors within the same compartment. The results obtained in the present studies using this approach suggest that the first GAG-core specific galactosyl transferase is substantially co-localized with one or more galactosyl transferases involved in the biosynthesis of certain subsets of asparagine-linked oligosaccharides. Figure 1 presents the rationale for the co-localization mapping of glycosyl transferases by specific donor depletion by diffusible glycoside acceptors. When 'static' or 'freeze-frame' Golgi preparations are supplied with a radiolabeled sugar nucleotide donor, glycosylation of endogenous acceptors occurs within those 'compartments' which have the necessary sugar nucleotide transporter and glycosyltransferase(s) co-localized with the correct acceptor molecules (Hayes and Varki, 1993; Hayes et ai, 1993) (Figure 1A ). These labeled acceptors may be further glycosylated by incubation with a cocktail of unlabeled sugar nucleotide donors if the same transporter and transferase constraints are met ( Figure IB) . Similarly, if an exogenous, freely diffusable acceptor for a specific glycosyltransferase is added to the Golgi incubations simultaneously with the labeled donor, this acceptor will be glycosylated in those 'compartments' which contain the correct sugar nucleotide transporter and the glycosidespecific glycosyltransferase ( Figure 1C ). Subsequent chase with unlabeled sugar nucleotide donors might also lead to further glycosylation as described above for the endogenous acceptors ( Figure ID ). Our hypothesis is that, if two glycosyltransferases are 'co-localized' in the same functional 'compartment' and use the same transported sugar nucleotide, they will compete with each other for the limited amount of donor. Since the amount of exogenous acceptor can be manipulated but endogenous acceptors are constant, glycosylation of endogenous acceptors will be compromised as the amount of glycoside acceptor increases, i.e., the exogenous acceptors act as a 'sink' for the transported sugar nucleotides and competitively inhibit glycosylation of endogenous acceptors. The results presented below give an example which fulfills the predictions of this hypothesis.
Results

Rationale for co-localization of glycosyltransferases using diffusible glycoside acceptors
Integrity of the Golgi fraction
The Golgi-enriched fraction from rat liver used in these studies are identical to those described previously (Etchison et ai, 1995) . The radiolabeled endogenous acceptors from the previous studies were used in these studies to allow a direct comparison with previous results. However, less extensive analyses have been carried out using another Golgi preparation, and these showed results similar to those to be described below. These Golgi preparations are intact and properly oriented; synthesis of radiolabeled products depends on transporter-mediated delivery of sugar nucleotides into the lumen. The Golgi fraction was 125-fold enriched in /31,4-galactosyltransf erase activity and transport-dependent galactosylation of endogenous and exogenous acceptors was enriched nearly 1000-fold. It was estimated that the Golgi fraction was contaminated with no more than 0.02% of soluble cytoplasmic proteins.
Since the Xyl/3MU acceptor used in these studies has a mildly hydrophobic aglycon which facilitates its diffusion across membranes, we considered the possibility that it might partition into the Golgi membranes and indirectly affect the glycosylation of endogenous acceptors. This seemed unlikely since the Golgi membrane concentration was 2 mg protein/ml and the maximum Xyl/3MU concentration used was 0.077 mg/ml (250 /xM) and most of the xyloside remained in the supernatant after the Golgi membranes were pelleted. To measure this directly, the Xyl-/3MU was extracted from the Golgi pellet incubated with 250 fiM Xyl/3MU (Etchison et ai, 1995) and quantified by HPLC using a fluorescence detector. These analyses indicated that the concentration of Xyl/3MU in the Golgi membranes and lumen (total pellet volume minus the 'void' volume (Perez and Hirschberg, 1987) ) was approximately 750 fiM. If we assume that all of this increased concentration is due to partitioning into the Golgi membranes and not into the lumenal space, this equals about 0.5 fig Xyl/3MU per mg Golgi protein (0.05%). If one argues that addition of 0.05% XylySMU to the Golgi membranes significantly affects glycosylation, then one must argue that a 0.05% shift in a component lipid would also alter glycosylation. This seems unlikely. Figure 2 shows that, at increasing concentrations of the Xyl/3MU exogenous acceptor, the synthesis of xyloside products reaches saturation between 30 and 40 pmol of H-Gal into TCA-precipitable endogenous acceptors decreases from 50 pmol/mg Golgi protein to a minimum of 38 pmol/mg with increasing concentrations of Xyl/3MU, corresponding to a maximal inhibition of approximately 25% (see also Table I ).
Decreased incorporation of^H-Gal into endogenous acceptors in the presence of Xyl/3MU
We considered the possibility that the product of the Xyl/3MU galactosylation, Gal/31 -»• 4Xyl/3MU, might inhibit the galactosylation of endogenous acceptors directly. First, if the product inhibition occurs in the same compartment in which it is synthesized, this would still mean that the glycosyltransferase inhibited by the xyloside product was co-localized. Secondly, if one postulates that it occurs in a second compartment as the result of diffusion from the site of synthesis, it would be unlikely that it could A Glycosyl transferase co-localization in Golgi reach inhibitory concentrations by diffusing out of one compartment into the incubation buffer and back into another compartment. The maximum concentration of Gal/31 -» 4Xyl/3MU which had diffused from the Golgi lumen by the end of the incubation with the highest concentration of Xyl/3MU was calculated to be less than 0.1 /JLM (12.5 pmol/250 /A] incubation; Etchison et ai, 1995) . It is unlikely that 50-100 nM Gal/81 -»• 4Xyl0MU could inhibit galactosylation. To directly investigate this possibility, we incubated the Golgi fraction with 100 and 250 /xM Gal/31 -» 4Xyl(benzyl in lieu of the Xyl/3MU (Gal/3104Xyl-/3MU is not available commercially). There was less than 5-10% inhibition of incorporation into total endogenous acceptors at these much higher concentrations. Taken together these results indicate that it is very unlikely that the xyloside product directly inhibits galactosylation of the endogenous acceptors.
Isolation of 3 H-Gal labeled N-linked oligosaccharides from endogenous acceptors
The SDS-solubilized endogenous acceptors (see Materials and methods) from incubations containing varying concentration of the Xyl)3MU acceptor and the control incubations were chromatographed on Sephacryl S200. Figure   3A shows that the incorporated 3 H-Gal eluted in or near the column void volume in the presence of SDS. All samples showed an identical elution profile. The fractions containing the 3 H Gal labeled products were pooled, lyophilized, extracted to remove the excess SDS, and digested with PNGase F. The PNGase F digests were rechromatographed on Sephacryl S200 ( Figure 3B ) and the released radiolabeled oligosaccharides eluting in or near the column totally included volume were pooled and processed for further analysis. Table I shows a summary of the isolated N-linked oligosaccharides released by PNGase F digestion. About 70-75% of the radiolabel incorporated was in relinked oligosaccharides. The relative distribution of incorporated radiolabel into PNGase F sensitive acceptors did not change as a function of xyloside acceptor, indicating that the competitive inhibition of incorporation into endogenous acceptors occurred proportionately in both PNGase F sensitive and resistant endogenous acceptors. Preliminary results indicate that most of the PNGase F resistant acceptors are O-linked glycans sensitive to /3-elimination.
The released N-linked oligosaccharides were analyzed by QAE-Sephadex ion exchange chromatography. Table  I shows of increasing concentrations of XyI/3MU. Since the total incorporation into total N-linked oligosaccharides decreased with increasing Xyl/3MU concentration, it is essential to calculate the amount of product made at different Xyl/SMU concentrations. As shown, there was a net decrease in pmol 3 H-Gal/mg Golgi protein incorporated into anionic N-linked oligosaccharides with increasing xyloside concentration. (As will be detailed in subsequent analyses, in Table IV , there was a larger net decrease in the neutral N-linked oligosaccharides.)
As was observed by Hayes and Varki (1993) , the majority of the 3 H-Gal labeled N-linked oligosaccharides were anionic (sialylated). Since the galactose label may be incorporated into endogenous products which had already been partially sialylated or may be sialylated after incorporation (or both), we analyzed incubations which did not include the chase with the sugar nucleotide cocktail ('No Chase') and which were chased without CMP-sialic acid (Table I: (sialylated) products does not involve intervesicular transport.
Analysis of 3 H-Gal labeled N-linked oligosaccharides by exoglycosidase digestions
The 3 H-Gal labeled N-linked oligosaccharides from endogenous acceptors were analyzed by digestion with specific exoglycosidases: a portion was digested with X. manihotis /31 -» 3 specific galactosidase (/31 -» 3 only); a portion with 5. pneumoniae /31 -> 4 specific galactosidase (/31 -> 4 only); and portions with A.ureafaciens sialidase (AUS) in combination with either the /31 -»3 specific galactosidase or the /31 -> 4 specific galactosidase (AUS + /31 -> 3 and AUS + /31 -» 4). The released 3 H-Gal was quantified by BioGel P2 chromatography as described in 'Materials and methods.' The X.manihotis /31 -» 3 specific galactosidase has a 500-fold kinetic preference for GalySl -» 3GlcNAc/31 -* R over Gal/31 -» 4GlcNAc/31 -> R (Wong-Madden and Landry, 1995). The S.pneumoniae (1 -» 4 specific galactosidase cleaves only Gal/31 -» 4GlcNAc(or GalNAc) /31 -> Golgi vesicles (0.5 mg) were incubated with 1 fiM UDP-[6-3 H]Gal and varying concentrations of Xyl/3MU as described under Materials and methods. The incubations with ilimaquinone (IQ), and with limited or no chase were as described in Materials and methods. The xyloside products made were quantified as described previously (Etchison et al., 1995 R at low enzyme concentrations (<100 mU/ml) (Paulson et al., 1978) . AUS is a 'broad spectrum' sialidase and cleaves al -> 3, al -» 6, and al -> 8 linked sialic acid residues (Uchida et al., 1979) . The incubation conditions with these enzymes detailed in the Materials and methods were established to give 90-100% cleavage while retaining the kinetic linkage specificity. The sum of the AUS + ySl -* 3 galactosidase and the AUS + /31 -» 4 galactosidase digestions was consistently in the range of 95-105%. Total /3-galactoside digestion was also determined using the 'broad spectrum' /3-galactosidase from bovine testes in the presence of AUS. Digestions were also carried out using the al -» 3 (and al -> 8) specific sialidase from NDV in combination with the y31 -» 4 specific galactosidase. These digestions indicated that these oligosaccharides contained very little Siaa2 -» 3Gal/31 -> 4 (data not shown). Thus, although the linkages of the Sia residues in the subsequent analyses are not shown, the majority of the Sia -» Gal/31 -> 4 are al -> 6 linkages; since the al,6 sialyltransferase does not sialylate Gal/31 -» 3 structures (Weinstein et al., 1982) , the Sia -» Gal/31 -» 3 structures must have al -»3 linkages. Table II shows the results of the specific exoglycosidase digestions. The values represent the average of three sets of analyses (except for the various controls which were analyzed twice). Duplicate assays within the same set of analyses varied by less than 5%; variation between different sets of digestions was usually between 5% and 15%. However, due to the limited incorporation and the extensive number of analyses done, it is not feasible to carry out all of the analyses in duplicate. In the standard incubations with increasing concentrations of Xyl/3MU, approximately 40% of the incorporated galactose was sialylated. This value did not change when an incubation was chased without exogenous CMP-Sia (Limited Chase), indicating that this sialylation did not require newly transported CMP- The 3 H-Gal labeled oligosaccharides released by PNGase F digestion of endogenous acceptors isolated from incubations containing varying Xyl/3MU concentrations were analyzed by digestion with specific exoglycosidases: A portion was digested with X.manihotis 01 -* 3 specific galactosidase (01 -> 3 only); a portion with S.pneumoniae 01 -» 4 specific galactosidase (/31 -> 4 only); and portions with A.ureafaciens sialidase in combination with either the 01 -» 3 specific galactosidase or the 01 -» 4 specific galactosidase (AUS + /31 -> 3 and AUS + 01 -» 4). The released 3 H-Gal was quantified by BioGel P2 chromatography as described in Materials and methods. The pmol of each structure was calculated from the percent digestion and the calculated total pmol from Table I . The values represent the average of three separate analyses. The control incubations with transport inhibitor (IQ) and the limited chase, and no chase are described in Materials and methods. a The values represent the difference of digestion in the presence and absence of sialidase. Sia; it occurred equally well using the pool of endogenous CMP-Sia in these Golgi preparations. In the absence of a chase (No Chase), only approximately 20% of the incorporated galactose became sialylated, indicating that about half the sialylation occurred during the incubation with UDP-[ 3 H]Gal and about half during the chase with cold sugar nucleotides. The incubation in the presence of ilimaquinone (IQ, Transport Inhibitor) was included in these analyses as a negative control to show that sialylation of the incorporated galactose was not dependent on vesicular traffic. Surprisingly, IQ appeared to promote the sialylation of Gal/31 -» 4 linked products.
The data in Table II show that there is a Xyl/8MU concentration dependent inhibition of 3 H-Gal incorporation into Gal/31 -» 3 linked products, reaching a maximum inhibition of about 40-50% at the highest xyloside concentration. Incorporation into Sia -> Gal/31 -» 3 products was not inhibited by incubation with Xyl/3MU. By contrast, incorporation into both sialylated and non-sialylated Gal/31 -» 4 linked products was only slightly inhibited (10-15%). These relationships are illustrated graphically in 
Analysis of products made in Triton permeabilized, transport-independent incubations
To determine if the observed inhibition of incorporation into Gal/31 -* 3 linkages was dependent on intact, transport-dependent compartmentalization, products synthesized by Triton permeabilized, transport-independent incubations (see Materials and methods) were analyzed. In these incubations the detergent-permeabilized Golgi were incubated with 50 /xM UDP-Gal rather than 1 /u.M as used in the transport-dependent incubation which concentrates the donor in the Golgi lumen. Table III shows that the amount of Xyl/3MU products increased approximately 50-fold in the transport-independent incubation. There was only a 15% decrease in incorporation into the N-linked oligosaccharides in the presence of the xyloside and this was equally distributed between /31 -» 3 and j81 -» 4 linked galactose. There was a 4-fold increase in galactosylation of endogenous acceptors and this was preferentially into /31 -* 4 linked Gal structures. In contrast with the standard incubations, there was no difference in the amount of nonsialylated Gal/31 -> 3 products made in the presence of the xyloside acceptor.
Profiling of i H-Gal labeled N-linked oligosaccharides by ConA Sepharose
To determine if the inhibition of /31 -* 3 galactosylation of endogenous acceptors occurred on selected classes of Nlinked oligosaccharides, the radiolabeled oligosaccharides Golgi vesicles (0.5 mg) were incubated using the standard, transport-dependent and the Triton permeabilized, transport-independent incubation conditions as described in Materials and methods. The products were analyzed as described in Tables I and II. were analyzed by ConA-Sepharose chromatography. There was no difference in the distribution of the radiolabeled products in the ConA I, ConA II, and ConA III fractions (Merkle and Cummings, 1987) regardless of the concentration of Xyl/SMU present during the incubations (data not shown). Thus, the inhibition of galactose incorporation was distributed among all types of branched oligosaccharides.
DEAE HPLCprofiling of 3 H-Gal labeled N-linked oligosaccharides
Since we had seen a slight increase in the per cent anionic oligosaccharides released by PNGase F (Table I ) and a decrease in the non-sialylated Gal/61 -» 3 structures (Table  II) , we fractionated the oligosaccharides by DEAE ion exchange HPLC (Guile et ai, 1994) into neutral, monosialyl, di-sialyl, and tri-sialyl structures. Figure 5 shows the fractionation profiles for two of the samples: panel A shows the profile of the oligosaccharides from the incubation without Xyl/3MU; panel B, that with 100 p.M Xyl/3MU. The oligosaccharides from the other samples were similarly fractionated. The percent distribution of the radioactivity in the four charge classes was used to calculate the distribution of incorporated 3 H-Gal into neutral, mono-, di-, and tri-sialyl oligosaccharides made in the presence of increasing Xyl/3MU concentration. These values (Table IV) show that there is a preferential decrease in the incorporation of radiolabeled galactose into the neutral and mono-sialylated oligosaccharide structures.
Analysis of incorporation of^H-Gal into neutral and mono-, di-, and tri-sialyl oligosaccharides
The neutral, mono-sialyl, and di-, and tri-sialyl oligosaccharides fractionated by DEAE HPLC were analyzed by linkage-specific glycosidase digestions as described above. The di-and tri-sialyl were pooled for these analyses. The above classification of the anionic oligosaccharides refers to the net number of sialic residues on the 3 H-Gal labeled oligosaccharides; it should be stressed that these sialyl groups are not necessarily located on the same branch as the 3 HGal label. Table V shows that the decreased incorporation into Gah31 -» 3 structures occurs almost entirely on neutral and monosialylated oligosaccharides. The previously observed smaller decrease in Gal/31 -> 4 structures is also were analyzed by DEAE ion exchange HPLC. A shows the profile of neutral, mono-sialylated, di-sialylated, and tri-sialylated oligosaccharides from endogenous acceptors labeled in the absence of Xyl/3MU; B shows a similar analysis of the oligosaccharides from endogenous acceptors labeled in the presence of 100 [iM Xyl/3MU. Similar analyses were carried out for all of the samples and the per cent distribution of [ 3 H]Gal label into the different charged species was used to quantify the distribution of neutral, mono-, di-, and trisialylated products versus XyI/3MU concentration as summarized in Table V. confined to the neutral and monosialylated products. The latter difference is more pronounced in these analyses since most of the Gal/81 -> 4 incorporation was into the di-and tri-sialyl products whereas only 10% of the Gal/31 -> 3 incorporation was in these structures. The sialylated Gal/31 -> 3 products were equally distributed between the The 3 H-Gal labeled oligosaccharides released by PNGase F digestion of endogenous acceptors were fractionated by DEAE ion exchange MFLC as described in materials and methods and as shown for two of the samples in Figure 5 . The percent of total cpm in each peak region and the calculated pmol/mg Golgi protein of PNGase F released oligosaccharides from endogenous acceptors were used to calculate the values listed below.
mono-sialyl and di-and tri-sialyl oligosaccharides, suggesting at least two subsets of /31 -» 3 transferases: one co-localized with a sialyltransferase and one not. Figure 6 shows an analysis by amine adsorption HPLC of the labeled neutral oligosaccharides from incubations with increasing concentration of Xyl/3MU. These results show a qualitative profile of the inhibition of galactose incorporation by Xyl/3MU. It is not possible to determine the entire structure of the peak which decreases but its size is consistent with a bi-or triantennary structure. Nevertheless, these results show that the galactosylation of endogenous acceptors which is inhibited in the presence of Xyl-/3MU is a subset of the total galactosylated acceptors.
Profiling of } H'-Gal-labeled neutral oligosaccharides by amine adsorption HPLC
Inhibition of galactosylation of endogenous acceptors by other glycoside acceptors
The results above suggest that the 'freeze-frame' Golgi glycosylation analysis should be useful to characterize the functional co-localization of other galactosyl and sialyltransferases. Figure 7 shows the results of galactosylation of two additional diffusible glycosides (panel A) and the corresponding inhibition of incorporation into endogenous acceptors (panel B). GalNAca-phenyl is a substrate for the O-linked glycan Core 1 /31,3-galactosyltransferase ; GlcNAqSMU, for )31,4 galactosyltransferase. At least 4 times as much GlcNAc/3MU products are made than XyljSMU but the maximal inhibition of endogenous galactosylation appears to be 70-75%. By contrast, about 50% more GalNAcaphenyl products are made than Xyl/3MU products but there is less inhibition of endogenous galactosylation. Thus, these acceptors, which are glycosylated by different galactosyltransferases, may be affecting different functional compartments. Further detailed analyses of these and other specific glycoside acceptors may give novel insight into the functional localization of other galactosyltransferases in the Golgi.
Discussion
Our premise for co-localizing multiple glycosyltransferases within the same Golgi 'compartment' is that they will compete for a limited pool of transported sugar nucleotides needed to glycosylate their acceptors. Since the amount of both endogenous acceptors and sugar donors is fixed, the introduction of increasing amounts of competitor should decrease the synthesis of the co-localized endogenous products. Overall, the results presented here support and substantiate this hypothesis using 'freeze frame' Golgi preparations, as previously defined (Hayes et ai, 1993) . We found that modest concentrations of an exogenous acceptor saturates the synthetic capacity of the Golgi system, and correspondingly decreases the synthesis of selected endogenous acceptors.
The 'freeze frame' Golgi glycosylation system provides a novel and unique approach to study the functional colocalization of glycosyltransferases with their appropriate acceptors in a biochemically functional environment which can be manipulated in vitro. (Figure 1A,B) . The original approach relied on the transport of exogenous radiolabeled The neutral, mono-sialyl. and di-and tri-sialyl 3 H-Gal labeled oligosaccharides obtained after fractionation by DEAE ion exchange HPLC (see Table IV ) were analyzed by specific /3-galactosidase digestions in the presence or absence of sialidase as described in Table II . The percent digestion and the calculated values in Table IV were used to calculate the pmol/mg Golgi protein of each structure show below. Figure 5 ) and analyzed by amine adsorption HPLC. Shown are the tritium detector traces for neutral oligosaccharides from endogenous acceptors labeled in the presence of 10, 50, and 100 /iM Xyl/3MU. The arrow marks a major peak which changes with increasing Xyl/3MU concentration.
sugar nucleotides into the Golgi to glycosylate endogenous acceptors which were "co-localized" with groups of glycosyl transferases (Hayes and Varki, 1993; Hayes etal., 1993) . The above studies showed and those of others (Kagiwada et al., 1993) have shown that it is very unlikely that vesicle fusion during isolation or incubation of these Golgi preparations occurs (see discussion by Hayes et al., 1993) . We extended this approach (Etchison et al., 1995) by introducing exogenous glycoside acceptors with moderately hydrophobic aglycones to facilitate diffusion across the Golgi membranes ( Figure 1C,D) . We chose XyljSMU as the exogenous glycoside acceptor since it has been extensively studied as an inhibitor of and alternate acceptor for glycosaminoglycan biosynthesis. This acceptor is only galactosylated by the GAG core specific Galactosyltransferase I (GAG GalT I) (Freeze et al., 1993) . Using the 'freeze frame' rat liver Golgi system, we showed that the GAG GalT I is not extensively co-localized with the GAG core Galactosyltransferase II (the next enzyme in the presumed biosynthetic pathway), but is co-localized with an al -* 3 sialyltransferase which converts the product of the GAG GalT I reaction into a glycolipid GM 3 -like structure, Sia«2 -» 3Gal/31 -» 4Xyl/3MU (Etchison et al, 1995) .
The results presented in the current studies show that, in the presence of saturating concentrations of Xyl/3MU, there is approximately 25% inhibition of incorporation of 3 H-Gal into endogenous glycoprotein acceptors. At least 70-75% of this inhibition occurred on N-linked oligosaccharides; the remainder most likely being in O-linked oligosaccharides since they were sensitive to /3-elimination. Approximately, 70-75% of the inhibition seen for all relinked chains was due specifically to a decrease in the synthesis of Gal/31 -> 3 linkages which were apparently not co-localized with an appropriate sialyltransferase. Incorporation into sialylated Gal/31 -» 3 linkages was not affected. Maximal inhibition of incorporation into nonsialylated Gal/31 -» 3 linkages was approximately 45%. These results suggest that a significant portion of the relinked glycan /31,3 galactosyltransferase (/31,3 GalT) is colocalized with GAG GalT I and they share the same pool of UDP-Gal. Also, a portion (ca. 30%) of the /31,3 GalT is co-localized with a sialyltransferase (presumably an a2,3 SiaT) and these transferases are probably not co-localized with the GAG GalT I since there is no inhibition in their synthesis. However, GAG GalT I is co-localized with an a2,3-sialyltransferase capable of sialylating Gal/31 -» 4Xyl- /3MU (Etchison et al., 1995) . The latter may be similar to an a2,3-sialyltransferase which can sialylate Gal/31 -» 4GlcNAc/3 -> R but not Gal/31 -> 3GlcNAc/3 -> R structures (Kitagawa and Paulson, 1994) . There was also a decrease (ca. 20-30%) in incorporation into Gal/31 -> 4 linkages. These results indicate that there is also some overlap of the /31,4 GalT with GAG GalT I. The affected structures were also confined to neutral and monosialyl oligosaccharide endogenous acceptors; the majority of the Gal/31 -» 4 linkages were in the di-and trisialylated acceptors, but these were not affected. All of the decreases in the glycosylation of the endogenous acceptors with added glycosides was abolished if the intact Golgi preparations were first permeabilized with detergent and labeled with higher concentrations of labeled donors. These conditions allowed the sugar nucleotides to have free access to the transferases and the endogenous acceptors making it independent of donor transport into the Golgi.
Thus, the results fulfill the essential predictions of the model proposed from Figure 1 , but, as with the other methods of localizing glycosyltransferases, it also has limitations. For instance, there may not always be a linear relationship between the amount of artificial glycoside product formed and a corresponding reduction in endogenous acceptors. This non-linearity could result from differences in the affinity constants of the glycosyltransferases for the sugar nucleotides and endogenous and exogenous glycoside acceptors. Our method clearly works best when the affinity constants of competitor and endogenous acceptors are similar. This ideal situation may not always be achieved, and it may even be difficult to predict when it would occur since the measured affinity of a solubilized transferase and glycoprotein acceptor could be quite different than within their native Golgi compartment. For these reasons, a lack of inhibition cannot always be taken to mean a lack of co-localization. Nevertheless, the results we obtained are consistent with the essential predictions of this approach. They provide the first example of how this method could be used for co-localizing multiple transferases from different glycosylation pathways using a single, well-defined artificial acceptor and its companion sugar nucleotide.
It is important to emphasize that the co-localizations defined by this method may not correspond to any of the traditional morphological entities such as particular Golgi stacks, tubules or vesicles. Instead, the functionally active transferases define their spatial relationships to each other by sharing sugar nucleotides delivered to them by sugar nucleotide transporters. Since we do not know the physical arrangement of sugar nucleotide transporters relative to the glycosyl transferases they serve, the boundaries of a 'compartment' are not morphologically defined; rather, they are defined by the availability of the sugar nucleotides once they are within the Golgi lumen.
As shown in Figure 7 , this approach is extendible, since similar incubations with glycoside acceptors specific for other glycosyltransferases also leads to reduced incorporation into endogenous acceptors. Additional detailed studies are necessary to determine if these glycoside acceptors are affecting distinct compartments. Since different glycosides and/or different aglycones will have different membrane permeability properties, it is important to carry out the incubations over a range of substrate concentrations and to show that both the synthesis of glycoside products and the inhibition of endogenous glycosylation follow inverse saturation curves. Furthermore, different glycoside substrates may have different affinities for their respective glycosyltransferases. Some glycoside substrates may be inhibitors as well as substrates for a glycosyltransferase. For example, GlcNAc/3MU is a substrate for GlcNAc /81,4 galactosyltransferase with a K m of about 50 /xM, but inhibits its own galactosylation above 200 /u.M (Portner et ai, 1996) . Appropriate controls will be necessary to show that the glycoside substrate itself does not inhibit endogenous glycosylation at the concentrations used. This approach should allow extensive mapping of the functional co-localization of many glycosyltransferases.
Materials and methods
Materials
UDP-[6-'H]galactose (lOCi/mmol) was purchased from American Radiolabeled Chemicals or prepared by the procedure of Hayes and Varki (1992) . Unlabeled UDP-Gal, UDP-GlcNAc, UDP-GlcUA, UDP-GalNAc, CMP-Neu5Ac, phenyl N-acetyl-a-D-galactosaminide, 4 methylumbelliferyl N-acetyl-/3-D-glucosaminide. and 4-methylumbelliferyl /3-Dxyloside were purchased from Sigma Chemical Co. Jack bean /3-galactosidase, Streptococcus pneumoniae /3-galactosidase, bovine testicular /3-galactosidase, Arthrobacter ureafaciens sialidase, Salmonella typhimurium sialidase, and Newcastle disease virus neuraminidase were from Oxford Glycosystems. Xanthomonas manihotis /3-1,3-galactosidase was purchased from New England BioLabs. PNGase F was purified from culture supernatants of Flavobacterium meningosepticum (Tarentino and Plummer, 1987) . Ilimaquinone (IQ) was a generous gift from Dr. Vivek Malhotra, UC San Diego, La Jolla, CA. Micro-Spin filters were manufactured by Lida Manufacturing Corp., Kenosha, WI. BioGel P2, Bio-Spin, and Poly-Prep columns were from BioRad Laboratories, Hercules, CA. C18 Spice cartridges and C18 modified silica gel resin were obtained from Analtech, Newark, DE. ConA Sepharose and Sephacryl S200 were from Pharmacia Fine Chemicals, Piscataway, NJ. Galj31 -» 4Xyl/3Benzyl was a generous gift from Dr. Jeff Esko, University of Alabama, Birmingham, AL.
Isolation of Golgi-enriched subcellular fraction
Golgi-enriched membranes were prepared from rat liver as described previously (Hayes et ai, 1993; Etchison et ai, 1995) . Purification of Golgi membranes was monitored by assaying for galactosyltransferase enrichment. UDP-Gal:GlcNAc Gal/31,4-galactosyltransferase was assayed exactly as described previously (Hayes et ai, 1993) . of intercompartmental transport, reactions were carried out as above after pretreatment of the Golgi-enriched fraction with 2 mM /V-ethylmaleimide (NEM) (Balch et ai, 1984) or 30 ju.M ilimaquinone (Takizawa etai, 1993) . In another reaction, the Golgi fraction was incubated using the standard conditions except that the chase contained only 5 piM UDP-Gal and UDP-GlcUA ('Limited Chase').
Sugar nucleotide transport-independent, permeabilized Golgi reactions were carried out with the following modifications to the standard incubation conditions: The Golgi membranes were permeabilized by the addition of 0.2% TX-100. the UDP-[ 3 H] Gal concentration was increased to 50 /i.M (25 /id; 2 Ci/mmol), and the concentration of the sugar nucleotides present during the chase was increased to 100 fiM.
To verify that the purified Golgi vesicle fraction was properly oriented and sealed, protease protection of radiolabeled endogenous acceptors was assayed using the methods described previously (Hayes et ai, 1993) . The capacity of the Golgi vesicles to transport UDP-Gal and transfer radiolabeled Gal to endogenous acceptors was quantified as described by Perez and Hirschberg (1987) .
Extraction and purification of endogenous glycoprotein products from Golgi incubations
The frozen pellets from the Golgi incubations were resuspended by sonication in 0.5 ml 70% ethanol. The samples were centrifuged at maximum speed in a microfuge for 5 min. The pellet was again resuspended by sonication in 0.5 ml 70% ethanol and the centrifugation repeated. The extracted pellets (XPs) were solubilized by sonication in 250/ul of 2% SDS in 10 mM Tris base for 10-20 s and stored frozen at -20°C until analyzed.
Isolation of N-linked oligosaccharides from endogenous acceptors
The solubilized Golgi pellets were applied to a 1.5 x 25 cm column of Sephacryl S200 equilibrated with 0.2% SDS in 0.02 M TrisHCl, pH 7.5. The column was eluted at a flow of 30 ml/h and 1 ml fractions were collected. The radiolabeled glycoproteins eluting in or near the column void volume were pooled and lyophilized. The lyophilized fractions were resuspended in 1 ml of a 1:1 mixture of acetone and absolute alcohol followed by the addition of 0.1 ml of water to dissolve the SDS. The insoluble glycoproteins were pelleted at maximum speed in a microfuge and the pellet was washed with acetone and dried with a stream of nitrogen until the acetone odor was no longer detectable. The pellet was dissolved in 0.1 ml of 2% SDS in 10 mM Tris base containing 10 mM /3-mercaptoethanol with heating at 65°C. The solubilized glycoproteins were adjusted to a final concentration of 0.2% SDS, 1% CHAPS, 10 mM /3-mercaptoethanol, and 0.1 M TrisHCl, pH 8.0, and digested with 5-10 mU/ml PNGase F at 37 °C for 16-20 h. The digest was terminated by heating at 100°C for 2 min and chromatographed on the S-200 column as described above. The released N-linked oligosaccharides eluting just before and in the column included volume were pooled. The SDS was precipitated by the addition of l/20th volume of saturated KG and incubating a 4°C overnight. The precipitated SDS was removed by centrifugation and the supernatant was lyophilized. The lyophilized N-linked oligosaccharides were dissolved in 0.5 ml of water and desalted on a 5 ml BioGel P2 spin column. The desalted N-linked oligosaccharides were lyophilized and dissolved in a minimal volume of water and stored frozen at -20 °C until analyzed. Incubations were done at room temperature (22-23°C) for 15 min and, unless otherwise noted, were chased for an additional 15 min after adding 6.25 /xl of a cocktail of unlabeled sugar nucleotides containing 220 piM each of UDP-Gal, UDP-GlcUA, CMP-Neu5Ac, UDP-GlcNAc, and UDP-GalNAc in 5 mM MgCl 2 in 50 /uM sodium maleate, pH 6.5, buffer (MgM) to give a final concentration of 5 mM each. The incubations were stopped by the addition of approximately 10 volumes of ice cold MgM buffer and immediately centrifuged for 20 min at 70,000 r.p.m. in the Beckman TLA-100.2 rotor in a TL100 ultracentrifuge. The pellets were gently surface washed three times with ice cold MgM buffer and frozen at-80°C.
Incubation of Golgi fraction with
To verify that the incubations with the Golgi-enriched fraction were dependent on the transport of sugar nucleotides, reactions were carried out as above in the presence of 0.2% TX-100. To demonstrate the absence
Glycosidase digestions
Sialidase and /3-galactosidase digestions were done in 10 /xl final volumes at room temperature for 16 to 20 h in 0.05 M citrate-PO 4 buffer containing 0.1% BSA at pH 5.0 or 5.5. All digestions were terminated by diluting to 50 /xl, heating at 100°C for 2 min, cooling, and microfuging. The amounts of glycosidases used per digestion, either alone or in combination, were as follows: AUS, 1 mU; NDV neuraminidase, 2 mU; S.pneumoniae /3-galactosidase, 1 mU; X.manihotis /3-galactosidase, 0.5 NEB units; bovine testes /3(-galactosidase, 5 mU. Sialidase digestions were monitored using QAE-Sephadex micro spin columns. Release of radiolabeled galactose after /3-galactosidase or sialidase plus /3-galactosidase digestion was quantified by separation of the products using 1 ml BioGel P2 spin columns.
Spin columns
QAE-Sephadex microspin columns were prepared using a 0.2 ml bed volume of QAE Sephadex in the filter basket of Micro-Spin filters. The resin was equilibrated with 10 mM Tris base and washed with three 200 /xl volumes of 10 mM Tris base before applying the sample. Elutions were carried out by centrifuging at 3000 r.p.m. for 2 min in a microfuge. Neutral oligosaccharides were eluted with three 200 /il washes with 10 mM Tris base; acidic oligosaccharides, with three 200 /u.1 washes with 250 mM NaCl in 10 mM Tris base.
ConA Sepharose microspin columns were prepared using a 0.2 ml bed volume in Micro-Spin filter. The resin was equilibrated with 0.01 M Tris-HCl, pH 7.5, containing 0.15 M NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , and 0.5 mM NaN 3 , and washed with three 200 n\ volumes of buffer before applying the sample. The column was eluted with three volumes of buffer (ConA-I), three volumes of 10 mM a-methyl-glucoside (ConA-II), and three volumes of 100 mM a-methyl-mannoside (pre-warmed to 60°C) (ConA-III).
BioGel P2 (200-400 mesh) spin columns were prepared using a 1 ml bed volume in BioRad Bio-Spin columns. The columns were washed with distilled water using gravity flow. Before use the columns were pre-spun at 300 x g for 5 min. The sample (40-70 //.I) was applied and spun at 300 x g for 5 min. The column was washed with 100 /il distilled water (300 X g; 5 min) and the eluate combined with the first eluate (column void volume). The column was eluted with 4 x 200 /nl washes (300 x g; 5 min) and the eluates combined (column included volume).
For desalting larger volumes, BioGel P2 spin columns were prepared using a 5 ml bed volume in BioRad Poly-Prep columns. The columns were pre-spun at 300 X g for 5 min before use. The sample to be desalted (150-500 /u.1) was applied and spun at 300 x g for 5 min. The column was washed with 500 AI! water and the combined eluates contained 95-100% of the desalted sample.
HPLC analysis of N-linked oligosaccharides
Analysis of neutral and anionic PNGase F released oligosaccharides by DEAE HPLC was carried out on a 7.5 mm X 7.5 cm DEAE-Toyopearl column (TosoHaas) using an ammonium formate, pH 6.0, gradient: The formate concentration was increased from 2 mM to 100 mM between 0 and 30 min; then, from 100 mM to 150 mM between 30 and 45 min. All of the anionic N-linked oligosaccharides eluted in the first portion of the gradient at pH 6.0 (Guile et a!., 1994) . Amine adsorption analysis of neutral N-linked oligosaccharides was done using a 4.5 mm X 25 cm Microsorb MV (NH 2 ) column and a gradient of 65-35% acetonitrile over 60 min. Radioactivity was monitored using an IN/US /3RAM detector.
